Arlington Capital Partners Acquires Avalign Technologies

Arlington Capital Partners, a private equity firm, has acquired Avalign Technologies. The company is a provider of precision manufacturing for implants and instruments, specialty instrumentation, cutting tools and cases for the medical device market.

Additionally, Avalign provides OEM (original equipment manufacturer) partners engineering design, development and project management capabilities from concept to market.

“We are extremely pleased to be partnering with Arlington Capital. Avalign is committed to improving patient outcomes by providing best-in-class medical devices through our industry leading end to end capabilities. We believe that Arlington Capital, which has deep expertise and an impressive track record in healthcare and precision manufacturing, is the ideal partner to help us achieve our goals. We would also like to thank RoundTable Healthcare Partners for all of their support and partnership to date,” said Forrest Whittaker, CEO of Avalign.

For more information, visit Avalign.

Sources: Press materials received from the company and additional information gleaned from the company’s website.